Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHZD.L Regulatory News (HZD)

  • There is currently no data for HZD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

4 Sep 2018 07:00

RNS Number : 6443Z
Horizon Discovery Group plc
04 September 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Horizon Discovery Group plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

ValueAct Capital Management, L.P.

City and country of registered office (if applicable)

San Francisco, United States of America

4. Full name of shareholder(s) (if different from 3.)v

Name

See Item 11

City and country of registered office (if applicable)

San Francisco, United States of America

5. Date on which the threshold was crossed or reachedvi:

31 August 2018

6. Date on which issuer notified (DD/MM/YYYY):

3 September 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

5.0%

5.0%

149,585,254

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Ordinary Shares

7,480,318

5.0%

SUBTOTAL 8. A

7,480,318

5.0%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

ValueAct Spring Master Fund, L.P.

5.0%

5.0%

VA Partners I, LLC

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

7,480,318 ordinary shares are held by ValueAct Spring Master Fund, L.P. VA Partners I, LLC is the general partner of ValueAct Spring Master Fund, L.P. ValueAct Capital Management, L.P. is the manager of ValueAct Spring Master Fund, L.P. ValueAct Capital Management, LLC is the general partner of ValueAct Capital Management, L.P. ValueAct Holdings, L.P. is the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC, and is the majority owner of the membership interests of VA Partners I, LLC. ValueAct Holdings GP, LLC is the General Partner of ValueAct Holdings, L.P.

 

Place of completion

San Francisco, United States of America

Date of completion

3 September 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLUGUUCBUPRPGW
Date   Source Headline
8th Jul 20207:00 amRNSNotice of Trading Update & Capital Markets Webinar
26th Jun 20207:00 amRNSDirector/PDMR Shareholding
18th Jun 20201:00 pmRNSResult of AGM
18th Jun 20201:00 pmRNSDirector/PDMR Shareholding
5th Jun 20205:34 pmRNSHolding(s) in Company
4th Jun 202011:11 amRNSHoldings in Company
29th May 20207:00 amRNSDirector/PDMR Shareholding
22nd May 20207:00 amRNSAnnual Report and Notice of AGM
5th May 20205:46 pmRNSHolding(s) in Company
5th May 20201:34 pmRNSHolding(s) in Company
4th May 20201:58 pmRNSDirector/PDMR Shareholding
4th May 20207:00 amRNSDirector/PDMR Shareholding
1st May 20207:00 amRNSBoard Changes
29th Apr 202010:43 amRNSHolding(s) in Company
27th Apr 20207:00 amRNSFull Year Unaudited Results 2019
17th Apr 20203:56 pmRNSResults of Placing
17th Apr 202011:00 amRNSProposed Placing and COVID-19 update
3rd Apr 202011:35 amRNSHolding(s) in Company
2nd Apr 20204:40 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 202010:56 amRNSHoldings in Company
27th Mar 20207:00 amRNSFull Year Results Deferral and COVID-19 Update
25th Mar 202011:20 amRNSHolding(s) in Company
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
17th Mar 202012:03 pmRNSPrice Monitoring Extension
27th Feb 202010:38 amRNSDirector/PDMR Shareholding
26th Feb 20207:00 amRNSPresentation Cowen Annual Health Care Conference
17th Feb 20207:00 amRNSTotal Voting Rights
14th Feb 20202:46 pmRNSHolding(s) in Company
4th Feb 20207:00 amRNSConfidential submission of Form F-1 to SEC
4th Feb 20207:00 amRNSTrading Update
27th Jan 20201:51 pmRNSBlock Listing Six Monthly Return
14th Jan 20207:00 amRNSUpdate on Base Editing Technology License
18th Dec 20197:00 amRNSPresentation at J.P. Morgan Healthcare Conference
16th Dec 201912:07 pmRNSSecond Price Monitoring Extn
16th Dec 201912:02 pmRNSPrice Monitoring Extension
13th Dec 20197:00 amRNSCollaboration with Mammoth Biosciences
4th Dec 201912:08 pmRNSSecond Price Monitoring Extn
4th Dec 201912:02 pmRNSPrice Monitoring Extension
4th Dec 20197:00 amRNSCompletion of Divestment of In Vivo Business Unit
8th Nov 20197:00 amRNSDivestment of In Vivo Business Unit
22nd Oct 20193:22 pmRNSAdditional Block Listing and Total Voting Rights
4th Oct 201912:07 pmRNSSecond Price Monitoring Extn
4th Oct 201912:02 pmRNSPrice Monitoring Extension
19th Sep 20193:30 pmRNSHolding(s) in Company
16th Sep 20197:00 amRNSHalf-year Report
12th Aug 201912:07 pmRNSSecond Price Monitoring Extn
12th Aug 201912:02 pmRNSPrice Monitoring Extension
26th Jul 20197:00 amRNSBlock Listing Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.